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Background
Oral lesions have been established as a clinical feature of
human immunodeficiency virus (HIV) seropositivity.
Treatment with Highly Active Antiretroviral Therapy
(HAART) has changed the course of infections with
HIV. This study correlates the oral lesion prevalence in
HAART and non-HAART groups in a cohort of HIV
seropositive patients in Southern India.
Methods
The study group consisted of 3485 HIV seropositive
patients who reported to the dental clinic of YRG
C A R E ,C h e n n a i ,I n d i a .O r a ll e s i o n sw e r ed i a g n o s e d
clinically based on EC Clearinghouse criteria and the
data was analyzed using SPSS software.
Results
In the study population, 92.3% of individuals had
acquired the infection through heterosexual contact.
The mean age of infected males and females was 35±8
and 30±8 years respectively and the mean CD4 count in
males and females was 385.53±226.76 and 284.36
±278.28 cells/µL respectively (p<0.05). Patients having
CD4 count < 200 (n=908) had more number of oral
lesions than patients with CD4 count > 200 (p<0.01).
Patients on HAART (n=1042) had a lesser number of
lesion than patients not on HAART (p<0.01). Of the
lesions, candidiasis was predominantly seen in the non-
HAART group (19.7%) as compared to the HAART
group (11.7%). Patients who were not on HAART
showed a higher prevalence of pseudomembranous
candidiasis (12.8% vs.7.9%, p<0.01) and angular cheilitis
(6.0% vs.3.7%, p<0.01).
Conclusion
Patients on Highly Active Antiretroviral Therapy
(HAART) demonstrate fewer oral lesions, which can
serve as markers of treatment efficacy. Long term fol-
low-up studies are necessary to validate these results.
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